Cover Image
市場調查報告書

體內神經刺激的全球市場 - 2019年為止的預測:各類型 (脊髓刺激,腦深部刺激,迷走神經刺激,薦椎神經刺激,胃電刺激),各用途,各地區

Internal Neurostimulation Market, by Type (Spinal Cord Stimulation, Deep brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electric Stimulation), by Application, by Geography - Analysis & Forecasts To 2019

出版商 MicroMarketMonitor 商品編碼 329349
出版日期 內容資訊 英文 88 Pages
訂單完成後即時交付
價格
Back to Top
體內神經刺激的全球市場 - 2019年為止的預測:各類型 (脊髓刺激,腦深部刺激,迷走神經刺激,薦椎神經刺激,胃電刺激),各用途,各地區 Internal Neurostimulation Market, by Type (Spinal Cord Stimulation, Deep brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electric Stimulation), by Application, by Geography - Analysis & Forecasts To 2019
出版日期: 2015年04月07日 內容資訊: 英文 88 Pages
簡介

2014年全球體內神經刺激市場中,脊髓刺激領域佔57.5%的最大佔有率。該市場預測將從2014年的27億8,800萬美元成長到2019年達到48億1,990萬美元,年複合成長率為11.6%。其次為腦深部刺激領域,預測將從2014年的8億6,120萬美元以年複合成長率12.9%的速度擴大,到2019年達到15億8,140萬美元的規模。

本報告提供全球體內神經刺激市場相關資料詳細分析,提供您各類型,各用途,各地區的趨勢,並彙整加入此市場的主要企業之詳細競爭趨勢與佔有率,簡介等資料。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 體內神經刺激市場
  • 推動市場因素和阻礙因素

第5章 各類型

  • 簡介
  • 全球脊髓刺激市場
  • 全球腦深部刺激市場
  • 全球迷走神經刺激市場
  • 全球薦椎神經刺激市場
  • 全球胃電刺激市場

第6章 各用途

  • 簡介
  • 帕金森氏症
  • 顫動
  • 憂鬱症
  • 其他

第7章 各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞洲
  • 其他

第8章 競爭環境

  • 企業佔有率分析
  • 各產品企業概要
  • 新產品上市
  • 法律規章認證
  • 合併·收購
  • 協定

第9章 各企業市場

  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • Depuy Synthes Companies
  • Enteromedics, Inc.
  • Medtronic, Plc.
  • St. Jude Medical
  • Synapse Biomedical, Inc.
  • Uroplasty, Inc.

第10章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HE 1046

Internal neurostimulation involves a surgical implantation of electrodes at specific areas, either in the dura mater or deep inside the brain. Medical practitioners measure the invasiveness of any surgical procedure or therapeutic device, based on incision size, collateral tissue damage, and recovery period. Thus, minimally invasive technologies are surgical techniques that reduce the physical impact of a medical procedure. The use of internal neurostimulation (minimally invasive) devices reduces the length of hospital stay, post-surgical complications, and improves the quality of life. The long-term cost savings associated with the use of minimally invasive neurostimulation devices has contributed to the significant growth of the internal neurostimulation market.

In addition to this, increasing neurostimulation research activities to treat diabetes, widespread awareness associated with the benefits of neurostimulation methods, and growing prevalence of neurological disorders have equally contributed to the overall growth of the global internal neurostimulation market.

The global internal neurostimulation market was valued at $4,850.1 million in 2014, and is expected to reach $8,585.1 million by 2019, at a CAGR of 12.1% from 2014 to 2019. The North American internal neurostimulation market was valued at $2,513.0 million in 2014, and is expected to reach $4,186.1 million by 2019, at a CAGR of 10.7% during the forecast period.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis-industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging and high-growth segments of the internal neurostimulation market, high-growth regions and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

  • Product Analysis and development:Detailed insights on upcoming technologies, research and development activities, and new product launches in the global internal neurostimulation market. Usage pattern/ penetration rate (in-depth trend analysis) of products (Segment wise), and purchasing data. Comprehensive coverage of product approvals and product recalls.
  • Market Development:Comprehensive information about emerging markets
  • Market Diversification:Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the global internal neurostimulation market. Detailed description regarding the related and unrelated diversification pertaining to this market.
  • Competitive Assessment:In-depth assessment of market shares and company share analysis of key players. Develop business strategies and manufacturing capabilities of leading players that enhance the bottom line of companies in the global internal neurostimulation market.
  • Product/ Brand Perception Analysis:Comprehensive study of customers perception and behavior through our inbuilt social connect tool (digital marketing language), by checking the virality and tonality of blogs.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET SEGMENTATION & COVERAGE
  • 1.3. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. INTEGRATED ECOSYSTEM OF THE INTERNAL NEUROSTIMULATION MARKET
  • 2.2. ARRIVING AT THE INTERNAL NEUROSTIMULATION MARKET SIZE
    • 2.2.1. TOP-DOWN APPROACH
    • 2.2.2. BOTTOM-UP APPROACH
    • 2.2.3. MACROINDICATOR-BASED APPROACH
  • 2.3. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. MARKET OVERVIEW

  • 4.1. INTRODUCTION
  • 4.2. INTERNAL NEUROSTIMULATION MARKET: COMPARISON WITH PARENT MARKET
  • 4.3. MARKET DRIVERS AND INHIBITORS

5. INTERNAL NEUROSTIMULATION MARKET, BY TYPE

  • 5.1. INTRODUCTION
  • 5.2. GLOBAL: SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY
  • 5.3. GLOBAL DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY
  • 5.4. GLOBAL SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY
  • 5.5. SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY, 2013-2019(USD MN)
  • 5.6. GLOBAL VAGUS NERVE STIMULATION MARKET, BY GEOGRAPHY
  • 5.7. GLOBAL GASTRIC ELECTRICAL STIMULATION MARKET, BY GEOGRAPHY

6. INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION

  • 6.1. INTRODUCTION
  • 6.2. GLOBAL INTERNAL NEUROSTIMULATION IN PARKINSON'S DISEASE , BY GEOGRAPHY
  • 6.3. GLOBAL INTERNAL NEUROSTIMULATION IN TREMOR, BY GEOGRAPHY
  • 6.4. GLOBAL INTERNAL NEUROSTIMULATION IN DEPRESSION, BY GEOGRAPHY
  • 6.5. GLOBAL INTERNAL NEUROSTIMULATION IN OTHER APPLICATIONS , BY GEOGRAPHY

7. INTERNAL NEUROSTIMULATION MARKET, BY GEOGRAPHY

  • 7.1. INTRODUCTION
  • 7.2. NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET
    • 7.2.1. NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION
    • 7.2.2. NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET, BY TYPE
  • 7.3. EUROPE INTERNAL NEUROSTIMULATION MARKET
    • 7.3.1. EUROPE INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION
    • 7.3.2. EUROPE INTERNAL NEUROSTIMULATION MARKET, BY TYPE
  • 7.4. ASIA: INTERNAL NEUROSTIMULATION MARKET
    • 7.4.1. ASIA INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION
    • 7.4.2. ASIA INTERNAL NEUROSTIMULATION MARKET, BY TYPE
  • 7.5. ROW INTERNAL NEUROSTIMULATION MARKET
    • 7.5.1. ROW INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION
    • 7.5.2. ROW INTERNAL NEUROSTIMULATION MARKET, BY TYPE

8. INTERNAL NEUROSTIMULATION MARKET: COMPETITIVE LANDSCAPE

  • 8.1. INTERNAL NEUROSTIMULATION MARKET: BY COMPANY
  • 8.2. COMPANY PRESENCE IN INTERNAL NEUROSTIMULATION MARKET, BY TYPE
  • 8.3. NEW PRODUCT LAUNCH
  • 8.4. REGULATORY APPROVALS
  • 8.5. AGREEMENTS

9. INTERNAL NEUROSTIMULATION MARKET, BY COMPANY (Overview, Financials, Products & Services, Strategy, and Developments)*

  • 9.1. BOSTON SCIENTIFIC CORPORATION (U.S.)
  • 9.2. CYBERONICS, INC. (U.S.)
  • 9.3. DEPUY SYNTHES COMPANIES (U.S.)
  • 9.4. ENTEROMEDICS, INC. (U.S.)
  • 9.5. MEDTRONIC, PLC. (U.S.)
  • 9.6. ST. JUDE MEDICAL (U.S.)
  • 9.7. SYNAPSE BIOMEDICAL, INC. (U.S.)
  • 9.8. UROPLASTY, INC. (U.S.)

*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company

10. APPENDIX

  • 10.1. CUSTOMIZATION OPTIONS
    • 10.1.1. PRODUCT ANALYSIS
    • 10.1.2. EPIDEMIOLOGY DATA
    • 10.1.3. SURGEONS/PHYSICIANS PERCEPTION ANALYSIS
    • 10.1.4. REGULATORY FRAMEWORK
  • 10.2. RELATED REPORTS
  • 10.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • 10.3.1. SNAPSHOTS

LIST OF TABLES

  • TABLE 1: GLOBAL INTERNAL NEUROSTIMULATION PEER MARKET SIZE, 2014 (USD MN)
  • TABLE 2: GLOBAL INTERNAL NEUROSTIMULATION MARKET: MACROINDICATORS, BY GEOGRAPHY, 2014 (USD MN)
  • TABLE 3: GLOBAL: INTERNAL NEUROSTIMULATION MARKET: COMPARISON WITH PARENT MARKET, 2013-2019 (USD MN)
  • TABLE 4: INTERNAL NEUROSTIMULATION MARKET, BY GEOGRAPHY, 2014 (USD MN)
  • TABLE 5: GLOBAL: INTERNAL NEUROSTIMULATION MARKET: DRIVERS AND INHIBITORS
  • TABLE 6: GLOBAL INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019 (USD MN)
  • TABLE 7: SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • TABLE 8: DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • TABLE 9: VAGUS NERVE STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • TABLE 10: GASTRIC ELECTRICAL STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • TABLE 11: GLOBAL INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION, 2013-2019 (USD MN)
  • TABLE 12: GLOBAL INTERNAL NEUROSTIMULATION IN PARKINSON'S DISEASE, BY GEOGRAPHY, 2013-2019 (USD MN)
  • TABLE 13: GLOBAL INTERNAL NEUROSTIMULATION IN TREMOR, BY GEOGRAPHY, 2013-2019 (USD MN)
  • TABLE 14: GLOBAL INTERNAL NEUROSTIMULATION IN DEPRESSION, BY GEOGRAPHY, 2013-2019(USD MN)
  • TABLE 15: GLOBAL INTERNAL NEUROSTIMULATION IN OTHER APPLICATIONS, BY GEOGRAPHY, 2013-2019(USD MN)
  • TABLE 16: GLOBAL INTERNAL NEUROSTIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • TABLE 17: NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION, 2013-2019 (USD MN)
  • TABLE 18: NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019 (USD MN)
  • TABLE 19: EUROPE INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION, 2013-2019 (USD MN)
  • TABLE 20: EUROPE: INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019 (USD MN)
  • TABLE 21: ASIA INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION, 2013-2019 (USD MN)
  • TABLE 22: ASIA INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019(USD MN)
  • TABLE 23: ROW INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION, 2013-2019 (USD MN)
  • TABLE 24: ROW INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019 (USD MN)
  • TABLE 25: INTERNAL NEUROSTIMULATION MARKET, BY COMPANY
  • TABLE 26: INTERNAL NEUROSTIMULATION MARKET: COMPANY SHARE ANALYSIS, 2013(%)
  • TABLE 27: GLOBAL INTERNAL NEUROSTIMULATION MARKET: NEW PRODUCT LAUNCH
  • TABLE 28: GLOBAL INTERNAL NEUROSTIMULATION MARKET: REGULATORY APPROVALS
  • TABLE 29: GLOBAL INTERNAL NEUROSTIMULATION MARKET: AGREEMENTS
  • TABLE 30: BOSTON SCIENTIFIC CORPORATION: REVENUE, BY BUSINESS SEGMENT, 2009 - 2013 (USD MN)
  • TABLE 31: BOSTON SCIENTIFIC: REVENUE, BY GEOGRAPHICAL SEGMENTS, 2009 - 2012 (USD MN)
  • TABLE 32: CYBERONICS, INC.: KEY FINANCIALS, 2009 - 2013 (USD MN)
  • TABLE 33: JOHNSON & JOHNSON, INC. : REVENUE, BY BUSINESS SEGMENT, 2009 - 2013 (USD MN)
  • TABLE 34: JOHNSON & JOHNSON, INC.: REVENUE, 2009 - 2013 (USD MN)
  • TABLE 35: MEDTRONIC, INC. : REVENUE, BY BUSINESS SEGMENT, 2009 - 2013 (USD MN)
  • TABLE 36: MEDTRONIC, INC. : REVENUE, BY GEOGRAPHICAL SEGMENT, 2009 - 2013 (USD MN)
  • TABLE 37: ST. JUDE MEDICAL: REVENUE, BY BUSINESS SEGMENT, 2011 - 2013 (USD MN)
  • TABLE 38: ST. JUDE MEDICAL: REVENUE, BY GEOGRAPHICAL SEGMENT, 2008 - 2013 (USD MN)
  • TABLE 39: UROPLASTY, INC. : REVENUE, BY GEOGRAPHICAL SEGMENT, 2011 - 2013 (USD MN)

LIST OF FIGURES

  • FIGURE 1: GLOBAL NEUROSTIMULATION MARKET: SEGMENTATION & COVERAGE
  • FIGURE 2: INTERNAL NEUROSTIMULATION MARKET: INTEGRATED ECOSYSTEM
  • FIGURE 3: RESEARCH METHODOLOGY
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: BOTTOM-UP APPROACH
  • FIGURE 6: MACROINDICATOR BASED APPROACH
  • FIGURE 7: GLOBAL INTERNAL NEUROSTIMULATION MARKET SNAPSHOT
  • FIGURE 8: INTERNAL NEUROSTIMULATION MARKET: COMPARISON WITH PARENT MARKET
  • FIGURE 9: GLOBAL : INTERNAL NEUROSTIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 10: GLOBAL: INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019 (USD MN)
  • FIGURE 11: GLOBAL: SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 12: GLOBAL: DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 13: GLOBAL: SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 14: GLOBAL: VAGUS NERVE STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 15: GLOBAL: GASTRIC ELECTRICAL STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 16: GLOBAL INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION, 2013-2019 (USD MN)
  • FIGURE 17: GLOBAL INTERNAL NEUROSTIMULATION IN PARKINSON'S DISEASE, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 18: GLOBAL INTERNAL NEUROSTIMULATION IN TREMOR, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 19: GLOBAL INTERNAL NEUROSTIMULATION IN DEPRESSION, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 20: GLOBAL INTERNAL NEUROSTIMULATION IN OTHER APPLICATIONS, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 21: NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET OVERVIEW, 2014 & 2019 (%)
  • FIGURE 22: NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION, 2013-2019 (USD MN)
  • FIGURE 23: NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET: APPLICATION SNAPSHOT
  • FIGURE 24: NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019 (USD MN)
  • FIGURE 25: NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET SHARE, BY TYPE, 2013-2019 (%)
  • FIGURE 26: EUROPE INTERNAL NEUROSTIMULATION MARKET OVERVIEW, 2014 & 2019 (%)
  • FIGURE 27: EUROPE INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION, 2013-2019 (USD MN)
  • FIGURE 28: EUROPE INTERNAL NEUROSTIMULATION MARKET: APPLICATION SNAPSHOT
  • FIGURE 29: EUROPE INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019 (USD MN)
  • FIGURE 30: EUROPE: INTERNAL NEUROSTIMULATION MARKET SHARE, BY TYPE, 2013-2019 (%)
  • FIGURE 31: ASIA INTERNAL NEUROSTIMULATION MARKET OVERVIEW, 2014 & 2019 (%)
  • FIGURE 32: ASIA INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION, 2013-2019 (USD MN)
  • FIGURE 33: ASIA INTERNAL NEUROSTIMULATION MARKET: APPLICATION SNAPSHOT
  • FIGURE 34: ASIA INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019 (USD MN)
  • FIGURE 35: ASIA INTERNAL NEUROSTIMULATION MARKET SHARE, BY TYPE, 2013-2019 (%)
  • FIGURE 36: ROW INTERNAL NEUROSTIMULATION MARKET OVERVIEW, 2014 & 2019 (%)
  • FIGURE 37: ROW INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION, 2013-2019 (USD MN)
  • FIGURE 38: ROW INTERNAL NEUROSTIMULATION MARKET: APPLICATION SNAPSHOT
  • FIGURE 39: ROW INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019(USD MN)
  • FIGURE 40: ROW: INTERNAL NEUROSTIMULATION MARKET SHARE, BY TYPE, 2013-2019 (%)
  • FIGURE 41: INTERNAL NEUROSTIMULATION: COMPANY PRODUCT COVERAGE, BY TYPE, 2013
  • FIGURE 42: BOSTON SCIENTIFIC CORPORATION REVENUE MIX, 2013
  • FIGURE 43: JOHNSON & JOHNSON, INC. REVENUE MIX, 2013
  • FIGURE 44: MEDTRONIC, PLC. REVENUE MIX, 2013
  • FIGURE 45: ST. JUDE MEDICAL. REVENUE MIX, 2013
Back to Top